Series B - Terray Therapeutics - 2024-10-17 - Crunchbase

Terray Therapeutics raised $120000000 on 2024-10-17 in Series B. Bedford Ridge Capital Bedford Ridge Capital is a private equity firm that focuses on financial advisory services.


Install CouponFollow Chrome Extension   CouponFollow Extension

$120000000
OFF

Series B - Terray Therapeutics - 2024-10-17 - Crunchbase

2 weeks from now

Terray Therapeutics raised $120000000 on 2024-10-17 in Series B. Bedford Ridge Capital Bedford Ridge Capital is a private equity firm that focuses on financial advisory services.

crunchbase.com

$120
OFF

Terray Therapeutics Closes Oversubscribed $120M Series B To …

2 weeks from now

Oct 17, 2024  · Terray Therapeutics Announces Series B of $120 million to Advance its Generative AI Pipeline of Small Molecule Therapeutics to the Clinic. ... October 17, 2024 09:00 AM …

businesswire.com

$120
OFF

Terray Therapeutics Closes Oversubscribed $120M Series B To …

2 weeks from now

LOS ANGELES, October 17, 2024--Terray Therapeutics Announces Series B of $120 million to Advance its Generative AI Pipeline of Small Molecule Therapeutics to the Clinic News Today's …

yahoo.com

$120
OFF

Terray Therapeutics Stock Price, Funding, Valuation, Revenue ...

2 weeks from now

Oct 17, 2024  · Terray Therapeutics's latest funding round was a Series B - II for $120M on October 17, 2024. Date. Round. Amount. Investors. ... Two Sigma Ventures invested in Terray …

cbinsights.com

$120
OFF

Terray Therapeutics Closes $120M Series B Funding Round

2 weeks from now

Oct 17, 2024  · Terray Therapeutic s, a Los Angeles, CA-based biotechnology company improving human health by enhancing small molecule drug development, raised $120M in Series B …

finsmes.com

$120
OFF

Terray Therapeutics Secures $120M Series B For Drug Innovation

2 weeks from now

Oct 17, 2024  · Author: Caleb Price Updated: 10-17-2024 09:54 AM. Terray Therapeutics Secures Significant Series B Investment. Terray Therapeutics, a dynamic player in the biotechnology …

investorshangout.com

$120
OFF

Terray Therapeutics Secures $120M In Series B Funding To …

2 weeks from now

Los Angeles, CA, October 17, 2024 (Business Wire) -- Terray Therapeutics has successfully raised $120 million in Series B funding to advance its innovative approach to small molecule …

jacobsmgt.com

$120
OFF

Terray Assembles $120M Series B To Advance AI-powered Molecules

2 weeks from now

Oct 17, 2024  · AI-focused Terray Therapeutics has doubled its series A funds, ... By Gabrielle Masson Oct 17, 2024 10:37am. ... which was double the size of Terray's series A, according to …

fiercebiotech.com

100%
OFF

Biotech Firm Terray Therapeutics Lands $120m Series B

2 weeks from now

Oct 17, 2024  · Home News Briefs Biotech firm Terray Therapeutics lands $120m Series B. Return to search. News Briefs. ... 17 October 2024. Share A-A + 100%. Bedford Ridge Capital and …

venturecapitaljournal.com

$120
OFF

Terray Therapeutics Raises $120M To Propel AI-Driven Small …

2 weeks from now

Oct 18, 2024  · Terray Therapeutics has raised $120 million in an oversubscribed Series B funding round, with hopes to advance its AI-powered small molecule drug pipeline. The funds will …

healtheconomics.com

$120
OFF

Data Is King For Terray's AI Platform, Which Prompts $120M Raise …

2 weeks from now

Oct 17, 2024  · In a splashy month for AI biotechs, Terray Therapeutics announced $120 million in fresh funding to build out its tNova drug discovery platform and advance its own pipeline of …

firstwordpharma.com

$120
OFF

Terray Therapeutics: $120 Million (Series B) Secured To Improve …

2 weeks from now

Oct 22, 2024  · Terray Therapeutics, a biotechnology company focused on improving human health by transforming the speed, cost, and success rate of small molecule drug development …

pulse2.com

$120
OFF

Terray Therapeutics Raises $120M Series B For Its AI Ways Of …

2 weeks from now

Oct 17, 2024  · Terray Therapeutics has raised a $120 million Series B round, aiming to get its first drug candidate into the clinic while advancing in its AI-fueled approach to making molecules. ...

endpts.com

$120
OFF

Terray Therapeutics Grabs $120M Series B - Vcnewsdaily.com

2 weeks from now

Oct 18, 2024  · Terray is a biotechnology company with the technology, data, and mindset to radically change the way we discover and develop small molecule therapeutics. The company …

vcnewsdaily.com

$120
OFF

Terray Therapeutics Closes Oversubscribed $120M Series B To …

2 weeks from now

Oct 17, 2024  · Terray Therapeutics Closes Oversubscribed $120M Series B to Advance Its Generative AI Pipeline of Small Molecule Therapeutics to the Clinic. ... October 17, 2024 at …

financialcontent.com

$60000000
OFF

Series A - Terray Therapeutics - 2022-02-15 - Crunchbase

2 weeks from now

Feb 15, 2022  · Terray Therapeutics raised $60000000 on 2022-02-15 in Series A. Madrona Madrona is a venture firm that invests in early- to late-stage companies in the Pacific …

crunchbase.com

FAQs about Series B - Terray Therapeutics - 2024-10-17 - Crunchbase Coupon?

What's new at Terray Therapeutics?

LOS ANGELES, October 17, 2024 -- (BUSINESS WIRE)--Terray Therapeutics, a biotechnology company improving human health by transforming the speed, cost, and success rate of small molecule drug development using computation integrated with novel data at scale, today announced Series B funding of $120 million. ...

How much money did Terray Therapeutics raise for a series B fundraise?

Terray Therapeutics has raked in $120 million for a series B fundraise as the AI-focused biotech aims to transform small molecule drug development. New investor Bedford Ridge Capital and existing investor NVentures—NVIDIA’s VC arm—led the funding round, which was double the size of Terray's series A, according to an Oct. 17 release. ...

How many investors does Terray therapeutics have?

Terray Therapeutics has 14 investors including NVentures and Bassil Dahiyat. How much funding has Terray Therapeutics raised to date? Terray Therapeutics has raised When was the last funding round for Terray Therapeutics? Terray Therapeutics closed its last funding round on Nov 9, 2023 from a Venture - Series Unknown round. ...

When did Terray Therapeutics close?

Terray Therapeutics closed its last funding round on Nov 9, 2023 from a Venture - Series Unknown round. Who are Terray Therapeutics's competitors? Alternatives and possible competitors to Terray Therapeutics may include Carisma Therapeutics, Moonwalk Biosciences, and Eikon Therapeutics. ...

Who are Terray's investors?

Other investors Maverick Capital, Goldcrest Capital, Madrona Ventures, Two Sigma Ventures, XTX Ventures, Digitalis Ventures, and Alexandria Ventures. In addition to the funding, Sid Shenai, who partnered with Bedford Ridge Capital on this financing, will join Terray’s board of directors. ...

What is Terray doing with tnova?

The company intends to use the funds to progress internal programs into clinical trials and further enhance its integrated AI platform, tNova, which it uses to power both internal and partnered programs. Led by CEO Jacob Berlin, Terray is a biotechnology company which change the way to discover and develop small molecule therapeutics. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension